Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients.

Yusuke Sasaki; Tetsuya Hamaguchi; Tatsuhiro Arai; Ayumu Goto; Takashi Ura; Kei Muro; Yasuhide Yamada; Kuniaki Shirao; Yasuhiro Shimada

首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients.

【24h】

Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients.

机译：I期研究与伊立替康，亚叶酸钙，推注和5-氟尿嘧啶连续输注（FOLFIRI）联合治疗晚期大肠癌的日本患者。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This FOLFIRI-180 regimen is manageable and effective in Japanese patients with metastatic colorectal cancer.

机译：该FOLFIRI-180方案在日本转移性结直肠癌患者中可控且有效。

著录项

来源
《Anticancer Research: International Journal of Cancer Research and Treatment》 |2014年第4期|共6页
作者
Yusuke Sasaki; Tetsuya Hamaguchi; Tatsuhiro Arai; Ayumu Goto; Takashi Ura; Kei Muro; Yasuhide Yamada; Kuniaki Shirao; Yasuhiro Shimada;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients. [J] . Yusuke Sasaki, Tetsuya Hamaguchi, Tatsuhiro Arai, Anticancer Research: International Journal of Cancer Research and Treatment . 2014,第4期

机译：I阶段I对日本患者晚期结直肠癌的伊替康，白杨和推注5-氟尿嘧啶（FOLFIRI）的联合治疗研究。
2. A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer. [J] . Kim SG, Oh SY, Kwon HC, Japanese journal of clinical oncology. . 2007,第10期

机译：伊立替康每两周一次，低剂量亚叶酸和大剂量推注并连续输注5-氟尿嘧啶（改良FOLFIRI）作为晚期或转移性胃癌患者的挽救疗法的II期研究。
3. A Phase II Study of Irinotecan with Bi-weekly, Low-dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFIRI) as Salvage Therapy for Patients with Advanced or Metastatic Gastric Cancer [J] . Seong-Geun Kim Sung Yong Oh Hyuk-Chan Kwon Suee Lee Jung Hwan Kim Sung-Hyun Kim and Hyo-Jin Kim Japanese Journal of Clinical Oncology . 2007,第10期

机译：伊立替康每两周一次，小剂量白叶三醇和小肠并连续输注5-氟尿嘧啶（改良FOLFIRI）作为晚期或转移性胃癌患者的挽救疗法的II期研究
4. Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer [C] . K. Sugiyama, A. Ishikawa, T. Watanabe International Gastric Cancer Congress . 2009

机译：组合化疗与多西紫杉醇和伊替康的疗效，作为晚期胃癌的第一或二线治疗
5. Use and outcomes of newer chemotherapeutic agents in colorectal cancer patients using Irinotecan as a case study. [D] . Obeidat, Nour A. 2008

机译：以伊立替康为例的结直肠癌患者中新型化疗药物的使用和结果。
6. A randomized Phase II clinical study of combining panitumumab and bevacizumab plus irinotecan 5-fluorouracil and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation [O] . Yuguo Liu, Lijuan Luan, Xingli Wang 2015

机译：帕尼单抗和贝伐单抗联合伊立替康5-氟尿嘧啶和亚叶酸钙（FOLFIRI）联合FOLFIRI作为二线治疗转移性结直肠癌和KRAS突变患者的第二阶段随机临床研究
7. A Phase II Study of Irinotecan with Bi-weekly, Low-dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFIRI) as Salvage Therapy for Patients with Advanced or Metastatic Gastric Cancer [O] . S.-G. Kim, S. Y. Oh, H.-C. Kwon, 2007

机译：伊替康与双每周，低剂量白杨和推注和连续输注5-氟尿嘧啶（改性Folfiri）作为先进或转移性胃癌的患者的救生疗法研究

Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients.

摘要

著录项

相似文献

相关主题

期刊订阅